Last Updated on June 9, 2026 by Staff
For a year now medicines called GLP-1 have been really helping people with obesity and type 2 diabetes. These medicines help control blood sugar, slow down digestion and reduce hunger, which allows people to lose weight and improve their health. Now researchers are trying to find out if new medicines can do even better.
One of the promising new medicines is called retatrutide. It is being tested in trials right now. The results from one of these trials called TRANSCEND-T2D-1 show that this medicine can really help control blood sugar and help people with type 2 diabetes lose a lot of weight.
What Makes Retatrutide Special
Retatrutide is different from medicines because of how it works. Other GLP-1 medicines only work on one hormone pathway. Retatrutide works on three pathways at the same time. It helps the body use three hormones: GLP-1, GIP and glucagon. GLP-1 helps control blood sugar and reduces hunger. GIP helps the body make insulin and use glucose better. Glucagon helps the body burn energy and use fat better.
By using these three pathways researchers hope that retatrutide can help people with diabetes and obesity more than medicines can. People take retatrutide as an injection, which is easy to do.
The Clinical Trial
The TRANSCEND-T2D-1 trial had 537 people with type 2 diabetes from 48 research centers in the United States, Mexico and India. All of these people were having trouble controlling their diabetes with diet and exercise.
The trial lasted for 40 weeks. Was designed to be fair and accurate. The people in the trial were divided into groups. Either got retatrutide or a placebo. The researchers were looking at two things: how well the medicine controlled blood sugar and how much weight people lost.
The results were really good. Showed that retatrutide is a powerful medicine for people with type 2 diabetes.
Great Results
One of the things about the trial was that nearly 90% of the people who got retatrutide were able to get their blood sugar under control. This is a deal because it means that they were able to get their HbA1c levels below 7.0%, which is what doctors consider good control.. Up to 40% of the people who got retatrutide were able to get their HbA1c levels below 5.7%, which is considered normal.
The people who got retatrutide also lost a lot of weight. The people who got the dose of retatrutide lost an average of 15.3% of their body weight which is a lot. The people who got the placebo only lost 2.6% of their body weight.
Many people also lost inches around their waist, which means they lost fat. This is good because visceral fat is bad for your health. The people who got retatrutide also had cholesterol levels and blood pressure, which is good for their heart health.
What This Means for the Future
The results of the trial are really. Suggest that retatrutide could be one of the best medicines available for type 2 diabetes and obesity. Because it works on pathways it can help with two of the biggest problems that people with diabetes face: high blood sugar and too much weight.
The safety results were also good. Nobody in the trial had a case of low blood sugar. The common side effects were nausea, diarrhea and vomiting but they were not usually severe.
Even though the results are promising researchers need to do studies to make sure that retatrutide is safe and effective in the long term. They also need to see how it works in groups of people and over a longer period of time.
If future trials confirm these results retatrutide could become a first-line treatment for people with type 2 diabetes. It could help people lose weight and get their blood sugar under control, which would be an advancement in diabetes care.
More and more people get diabetes. New medicines like retatrutide offer hope for better health and a lower risk of long-term problems.